AS Infortar (TAL:INF1T)

Market Cap	991.52M
Revenue (ttm)	1.45B
Net Income (ttm)	124.61M
Shares Out	20.44M
EPS (ttm)	5.97
PE Ratio	8.13
Forward PE	n/a
Dividend	3.00 (6.19%)
Ex-Dividend Date	Dec 3, 2025

Volume	479
Average Volume	574
Open	48.30
Previous Close	48.30
Day's Range	48.30 - 48.50
52-Week Range	35.05 - 50.50
Beta	n/a
RSI	53.71
Earnings Date	Aug 4, 2025

About Marinus Pharmaceuticals

AS Infortar, together with its subsidiaries operates in the maritime transportation, energy, and real estate sectors in Estonia, Finland, Lithuania, Latvia, rest of European Union, and internationally. The company operates through Maritime transport, Energy, Real Estate and Other segments. It involves in sales and trading, infrastructure, and production of natural gas; sells electricity, including green electricity generated in solar parks, and engages in international energy trading; and biomethane production. The company also leases and devel...

• Industry: Investors, not elsewhere classified
• Founded: 1997
• Employees: 6,164
• Stock Exchange: Nasdaq Tallinn
• Ticker Symbol: INF1T

Financial Performance

In 2024, AS Infortar's revenue was 1.37 billion, an increase of 26.47% compared to the previous year's 1.08 billion. Earnings were 191.25 million, a decrease of -34.90%.